<DOC>
	<DOCNO>NCT00370591</DOCNO>
	<brief_summary>Comparison two asthma treatment lung function measure .</brief_summary>
	<brief_title>Study Of Airway Physiology In Adults . SERETIDE DISKUS® Inhaler FLIXOTIDE® Inhaler Are Trademarks GSK Croup Companies .</brief_title>
	<detailed_description>Single centre , randomise , double-blind , comparator study demonstrate superiority salmeterol/fluticasone propionate combination product 50/100mcg bd fluticasone propionate 100mcg bd respect improvement airway physiology ( sRAW ) adult persistent asthma treat 4 week .</detailed_description>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion : Physician document diagnosis asthma present least 6 month . Receiving total daily dose 200500mcg/day beclomethasone dipropionate equivalent least 4 week prior start runin period . Exclusion : Has 3 course oral corticosteroid 12 month previous visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Inhaled corticosteroid</keyword>
	<keyword>Asthma</keyword>
</DOC>